Alex Rogers

Alex Rogers is president of Qualcomm Technology Licensing (QTL) and Global Affairs. As the head of the company’s licensing business, Rogers is responsible for the strategic direction and oversight of QTL, including the management of all day-to-day operations and has responsibility for the IP Department, including the patent, copyright and trademark practice groups. As head of Global Affairs, Rogers is responsible for government affairs, public affairs, export compliance, and corporate responsibility.

Rogers has led QTL since 2016, managing intellectual property, regulatory and commercial matters, as well as ensuring continued growth and monetization of QTL’s existing and future licensing programs through negotiation of significant licensing agreements. Under his leadership, Rogers has launched new licensing programs, negotiated and supervised the conclusion of key license agreements, initiated programs to manage IP development in coordination with Qualcomm’s extensive research and development activities, and initiated programs to assist licensees in the efforts to adopt new technology and reach new markets. He has also negotiated the resolution of regulatory matters, both before joining QTL and after. Rogers’ management responsibilities extended to global affairs in 2021, given his extensive work with governments and regulators around the world. He also oversaw the IP Department between 2019 – 2022.

After joining Qualcomm in 2001, Rogers held various leadership roles focused on IP and commercial litigation matters. In 2007, he was promoted to senior vice president, became head of Qualcomm’s litigation function and was then promoted to deputy general counsel before transitioning to QTL in 2016. Rogers is a member of Qualcomm’s Executive Committee and reports directly to Qualcomm president and chief executive officer Cristiano Amon.

Prior to joining Qualcomm, Rogers was a partner with the law firm of Gray, Cary, Ware & Friedenrich (now DLA Piper), specializing in intellectual property litigation for various technology companies.

Rogers holds M.A. and B.A. degrees in English Literature from Georgetown University and a J.D. degree from Georgetown University Law Center. He also studied for one year at the Hebrew University in Israel and taught history and literature in Washington, D.C. for four years. Rogers currently sits on the Georgetown University Law Center Board of Visitors.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More